Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.

Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB, Dispenzieri A, Kumar S, Clark RJ, Baris D, Hoover R, Rajkumar SV.

Blood. 2009 May 28;113(22):5412-7. doi: 10.1182/blood-2008-12-194241. Epub 2009 Jan 29.

2.

A monoclonal gammopathy in search of clinical significance: 57 years later.

Go RS, Doyle LM.

Blood. 2009 Sep 10;114(11):2355-6; author reply 2356-7. doi: 10.1182/blood-2009-06-229120. No abstract available.

3.

A monoclonal gammopathy precedes multiple myeloma in most patients.

Weiss BM, Abadie J, Verma P, Howard RS, Kuehl WM.

Blood. 2009 May 28;113(22):5418-22. doi: 10.1182/blood-2008-12-195008. Epub 2009 Feb 20.

4.

Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance.

Vachon CM, Kyle RA, Therneau TM, Foreman BJ, Larson DR, Colby CL, Phelps TK, Dispenzieri A, Kumar SK, Katzmann JA, Rajkumar SV.

Blood. 2009 Jul 23;114(4):785-90. doi: 10.1182/blood-2008-12-192575. Epub 2009 Jan 29.

5.

Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study.

Dispenzieri A, Katzmann JA, Kyle RA, Larson DR, Melton LJ 3rd, Colby CL, Therneau TM, Clark R, Kumar SK, Bradwell A, Fonseca R, Jelinek DF, Rajkumar SV.

Lancet. 2010 May 15;375(9727):1721-8. doi: 10.1016/S0140-6736(10)60482-5. Erratum in: Lancet. 2010 Jul 31;376(9738):332.

6.
7.

[Analysis of serum levels of Dickkopf-1 (DKK-1) in monoclonal gammopathy of undetermined significance and multiple myeloma].

Ščudla V, Petrová P, Pika T, Lochman P, Minařík J, Bačovský J, Srovnalík K.

Cas Lek Cesk. 2015;154(4):181-8. Czech.

PMID:
26357861
8.

Monoclonal gammopathy: natural history studied with a retrospective approach.

Steingrimsdottir H, Haraldsdottir V, Olafsson I, Gudnason V, Ogmundsdottir HM.

Haematologica. 2007 Aug;92(8):1131-4.

9.

[Study of monoclonal gammopathy in Kagawa Prefectural Central Hospital].

Uchida M, Taida N, Kanao M, Kagamihara H, Kuwajima M.

Rinsho Byori. 2004 Jul;52(7):574-9. Japanese.

PMID:
15344556
10.

The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.

Bergón E, Miravalles E, Bergón E, Miranda I, Bergón M.

Clin Chem Lab Med. 2005;43(1):32-7. Erratum in: Clin Chem Lab Med. 2005;43(3):349.

PMID:
15653439
11.

The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.

Sigurdardottir EE, Turesson I, Lund SH, Lindqvist EK, Mailankody S, Korde N, Björkholm M, Landgren O, Kristinsson SY.

JAMA Oncol. 2015 May;1(2):168-74. doi: 10.1001/jamaoncol.2015.23.

PMID:
26181017
12.

Does my patient with a serum monoclonal spike have multiple myeloma?

Bianchi G, Ghobrial IM.

Hematol Oncol Clin North Am. 2012 Apr;26(2):383-93, ix. doi: 10.1016/j.hoc.2012.02.009. Review.

13.

Monoclonal gammopathy of undetermined significance.

Kyle RA, Rajkumar SV.

Clin Lymphoma Myeloma. 2005 Sep;6(2):102-14. Review.

PMID:
16231848
14.

[Monoclonal gammopathy of undetermined significance].

Chaïbi P, Merlin L, Thomas C, Piette F.

Ann Med Interne (Paris). 2002 Nov;153(7):459-66. Review. French.

PMID:
12598832
15.

Laboratory and clinical characterization of monoclonal gammopathy in Taiwanese.

Lee LN, Jan IS, Tien HF, Lin JS, Lo SC, Cheng WC.

J Formos Med Assoc. 2002 Feb;101(2):91-7.

PMID:
12099210
16.
17.

[Contribution to the evaluation of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and in individual clinical stages of multiple myeloma].

Scudla V, Petrová P, Minarík J, Pika T, Budíková M, Bacovský J, Repovský S.

Vnitr Lek. 2010 Jun;56(6):591-601. Czech.

PMID:
20681472
18.

[Malignant transformation of monoclonal gammopathy of undetermined significance].

Decaux O, Avet-Loiseau H, Grosbois B.

Presse Med. 2007 Dec;36(12 Pt 3):1985-96. Epub 2007 May 16. Review. French.

PMID:
17509811
19.

Advances in understanding monoclonal gammopathy of undetermined significance as a precursor of multiple myeloma.

Weiss BM, Kuehl WM.

Expert Rev Hematol. 2010 Apr;3(2):165-74. doi: 10.1586/ehm.10.13. Review.

20.

[Analysis of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and multiple myeloma].

Scudla V, Budíková M, Petrová P, Minarík J, Pika T, Bacovský J, Adamová D, Langová K; Ceská myelomová skupina.

Klin Onkol. 2010;23(3):171-81. Czech.

PMID:
20608327
Items per page

Supplemental Content

Write to the Help Desk